| 000 | 01856 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250513100745.0 | ||
| 264 | 0 | _c19970220 | |
| 008 | 199702s 0 0 eng d | ||
| 022 | _a0014-2999 | ||
| 024 | 7 |
_a10.1016/0014-2999(96)00168-9 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aChao, C C | |
| 245 | 0 | 0 |
_aCross-resistance to cis-diamminedichloroplatinum(II) of a multidrug-resistant lymphoma cell line associated with decreased drug accumulation and enhanced DNA repair. _h[electronic resource] |
| 260 |
_bEuropean journal of pharmacology _cJun 1996 |
||
| 300 |
_a213-22 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xmetabolism |
| 650 | 0 | 4 |
_aAphidicolin _xpharmacology |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 |
_aCisplatin _xmetabolism |
| 650 | 0 | 4 |
_aColchicine _xpharmacology |
| 650 | 0 | 4 |
_aDNA Adducts _xmetabolism |
| 650 | 0 | 4 |
_aDNA Repair _xdrug effects |
| 650 | 0 | 4 |
_aDNA, Neoplasm _xisolation & purification |
| 650 | 0 | 4 |
_aDoxorubicin _xpharmacology |
| 650 | 0 | 4 | _aDrug Resistance, Neoplasm |
| 650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
| 650 | 0 | 4 | _aGene Expression |
| 650 | 0 | 4 | _aGenes, MDR |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLymphoma, Large B-Cell, Diffuse _xgenetics |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMitomycin _xpharmacology |
| 650 | 0 | 4 | _aPolymerase Chain Reaction |
| 650 | 0 | 4 |
_aPuromycin _xpharmacology |
| 650 | 0 | 4 | _aSpectrophotometry, Atomic |
| 650 | 0 | 4 | _aTranscription, Genetic |
| 650 | 0 | 4 | _aTransfection |
| 650 | 0 | 4 | _aTumor Cells, Cultured |
| 650 | 0 | 4 |
_aVerapamil _xpharmacology |
| 650 | 0 | 4 |
_aVincristine _xpharmacology |
| 773 | 0 |
_tEuropean journal of pharmacology _gvol. 305 _gno. 1-3 _gp. 213-22 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0014-2999(96)00168-9 _zAvailable from publisher's website |
| 999 |
_c8807865 _d8807865 |
||